Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface Malignancies
Crossref DOI link: https://doi.org/10.1245/s10434-015-4644-7
Published Online: 2015-06-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chia, Claramae Shulyn
Glehen, Olivier
Bakrin, Naoual
Decullier, Evelyne
You, Benoit
Gilly, François Noël
Passot, Guillaume
Text and Data Mining valid from 2015-06-04